Previous Article | Next Article ![]()
Infection and Immunity, July 2006, p. 4246-4253, Vol. 74, No. 7
0019-9567/06/$08.00+0 doi:10.1128/IAI.01620-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Microbiology and Immunology, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul 110-799, Republic of Korea
Received 4 October 2005/ Returned for modification 21 November 2005/ Accepted 11 April 2006
|
|
|---|
|
|
|---|
Most of the intracellular bacteria exploit at least two distinct pathways, clathrin- and caveola-mediated endocytic pathways, to enter the nonprofessional phagocytes after making contact with the cell surface (40). It remains unclear whether O. tsutsugamushi enters the host cells by a clathrin-mediated or caveola-mediated pathway. Clathrin coats are known to be involved in receptor-mediated and fluid-phase endocytosis, from plasma membranes to early endosomes (42). Several intracellular bacteria, such as Chlamydia spp. (26), Neisseria gonorrhoeae (15), Citrobacter freundii (30), and enterohemorrhagic Escherichia coli (25), are known to use the clathrin-mediated endocytosis pathway. Caveolae are small, flask-shaped invaginations of the plasma membrane, characterized by high contents of cholesterol and glycosphingolipids and by the presence of caveolin (34). FimH-expressing E. coli (44), Mycobacterium bovis (10), Campylobacter jejuni (53), and Mycobacterium kansasii (35) have been shown to exploit the caveola-mediated endocytosis pathway to enter the host cells.
Internalized bacteria are usually carried by a membrane-bound endosome. The invading microorganisms may remain in the developing endosomes and exploit them to survive in the low-pH environment of lysosomes (27). During this process, the dynamic changes of endosomal vesicles, including the delivery of hydrolytic enzymes and proton pumps from other intracellular compartments, occur, and the intraphagosomal pH of the endocytic vesicles is lowered (3). To cope with this harsh environment, the intracellular bacteria have developed different strategies. For example, Coxiella burnetii (27) thrives in an acidic compartment. Mycobacterium avium (8) and Legionella pneumophila (17) attenuate the acidic pH of the compartment in which they reside. Salmonella enterica serovar Typhimurium has developed mechanisms to modulate the redistribution of endosomal and lysosomal markers (16). Other intracellular pathogens, such as Listeria monocytogenes (36) or Rickettsia prowazekii (52), have developed mechanisms to lyse the phagosomal membrane and escape into the cytoplasm. In the case of O. tsutsugamushi, the organism lyses the phagosomal membranes with an unknown mechanism and is released into the cytoplasm at an early stage of infection. In this study, we used a variety of approaches to elucidate the endocytosis and infection pathways of O. tsutsugamushi in nonprofessional phagocytes. Our results show that O. tsutsugamushi exploits clathrin-dependent endocytosis to enter the nonprofessional phagocytes. The infectivity of this intracellular bacterium was significantly reduced by pharmacological inhibitors that block the clathrin-dependent endocytic pathway but not by filipin III, which inhibits the caveola-dependent pathway. In addition, we also demonstrated that O. tsutsugamushi organisms were colocalized with early and late endosomes sequentially in an early stage of infection and that the movement of this intracellular bacterium from the endocytic pathway is dependent on the acidification process of the endocytic vesicle.
|
|
|---|
Inhibition assays. Cells were grown on 12-mm-diameter glass coverslips and pretreated for 1 h with chemical reagents before infection by O. tsutsugamushi Boryong (2.4 x 106 or 2.4 x 107 ICU). The concentration of each chemical was as follows: chlorpromazine hydrochloride, 10 µM in distilled water (Calbiochem); monodansylcadaverine, 0.2 mM in acetic acid (Sigma); sucrose, 0.3 M in DMEM (Sigma); filipin III, 1.5 mM in dimethyl sulfoxide (Sigma); NH4Cl, 20 mM in DMEM (Sigma); and bafilomycin A, 20 nM in DMEM (Calbiochem). Control cells were incubated in medium without inhibitors. After infection by O. tsutsugamushi for designated times, each cell was stained with antibody against O. tsutsugamushi, and the infectivity of O. tsutsugamushi was examined. One hundred cells were counted for each experimental set, and the results were expressed as the mean number of bacteria/counted cells ± the standard deviation of the means. To check the effects of these chemicals on the viability and function of cells, cells were assayed, and the viability and infectivity of those that had been pretreated were compared to those from which the chemicals had been washed.
Immunofluorescence assay.
O. tsutsugamushi was stained with monoclonal antibody (KI-37) against the Boryong strain's 56-kDa outer membrane protein (33) or human patient polyserum. Anti-clathrin heavy chain, anti-caveolin 1, anti-early endosome antigen 1 (EEA1), anti-lysosome-associated protein 2 (LAMP2) (BD Biosciences), or anti-
-adaptin (Santa Cruse Biotechnology) antibody was used for the staining of cellular organelles. Fluorescein isothiocyanate (FITC) or tetramethyl-rhodaminyl isothiocyanate (TRITC)-conjugated goat anti-mouse immunoglobulin G (IgG), TRITC-conjugated goat anti-rabbit IgG (Santa Cruse Biotechnology), or Alexa Fluor 568 or Alexa Fluor 488 goat anti-mouse IgG (Molecular Probes) was used as the secondary antibody. Immunofluorescence assays were performed as described previously (22). In brief, the infected monolayer of cells was washed three times with PBS, fixed in PBS containing 4% paraformaldehyde for 10 min at room temperature, and permeabilized in a 0.2% Triton X-100 solution. Subsequently, cells were incubated for 30 min at 37°C with primary antibodies. After incubation, cells were washed three times and incubated at 37°C with secondary antibodies diluted in PBS. Cells were examined under a confocal microscope (Carl Zeiss AG, Germany). Images of cellular sections were produced every 1 µm, and all images were analyzed and processed using Adobe Photoshop v. 6.0 software (Adobe Systems).
|
|
|---|
-adaptin among six dots (Fig. 1B). In contrast, none of the O. tsutsugamushi colocalized with caveolin 1 (Fig. 1C). This suggests that O. tsutsugamushi and clathrin-coated vesicles coexist in the same endocytic compartments. By contrast, there was no evident colocalization of O. tsutsugamushi with caveolin 1, a marker for the caveola-dependent pathway (Fig. 1C). Colocalization of clathrin or
-adaptin with O. tsutsugamushi within 30 min after infection showed that O. tsutsugamushi was internalized by the host cells by clathrin-mediated endocytosis. With L929 cells, other nonprofessional phagocytes infected with O. tsutsugamushi, similar results could be observed (data not shown).
![]() View larger version (19K): [in a new window] |
FIG. 1. Colocalization of O. tsutsugamushi with clathrin, -adaptin, or caveolin 1. ECV304 cells were infected with O. tsutsugamushi for 30 min. The cells were subjected to anti-clathrin (A), anti- -adaptin (B), or anti-caveolin 1 (C) antibodies with anti-O. tsutsugamushi antibody. Colocalization of each protein (green) with O. tsutsugamushi (red) was examined with a confocal microscope. Colocalization of each protein and O. tsutsugamushi produced yellow fluorescence. The ratios are the number of O. tsutsugamushi organisms that colocalized with clathrin (A), -adaptin (B), or caveolin 1 (C) to the total number of infecting O. tsutsugamushi organisms. The colocalizations of O. tsutsugamushi with clathrin, -adaptin, or caveolin 1 are indicated by arrows. Bars, 10 µm.
|
![]() View larger version (16K): [in a new window] |
FIG. 2. Inhibitory effects of endocytosis-disrupting agents on O. tsutsugamushi invasion of nonprofessional phagocytes. ECV304 (A) and L929 (B) cells were infected at 2 x 105 ICU (about 15 O. tsutsugamushi bacteria were found per cell) for 2 h in the presence or absence of the inhibitors. Cells were labeled with KI-37 (monoclonal antibody against the Boryong strain's 56-kDa outer membrane protein) and goat anti-mouse IgG-FITC. The number of infecting bacteria in every 100 cells was counted by observation with a fluorescence microscope. The concentrations of inhibitors were maintained throughout the study. Each experiment was performed a minimum of three times. Inhibition assays were performed by preincubation of inhibitors for 30 min followed by O. tsutsugamushi infection for 2 h. The concentrations of inhibitors were as follows: MDC, 0.1, 0.2, 0.3, and 0.4 mM; CPZ, 1, 5, 10, and 25 µM; SUC, 0.1, 0.2, and 0.3 M; and filipin III (FIL), 0.375, 0.75, and 1.5 mM. CON, control.
|
![]() View larger version (15K): [in a new window] |
FIG. 3. Colocalization of O. tsutsugamushi with EEA1 (A) and LAMP2 (B). Representative immunofluorescence with the confocal microscopic images of ECV304 cells infected with O. tsutsugamushi for the time periods indicated below. Cells were fixed, permeabilized, and double labeled with human serum against O. tsutsugamushi (goat anti-human rhodamine conjugate) and anti-EEA1 (Alexa Fluor 488) or LAMP2 (Alexa Fluor 488). (A) Merged images of EEA1 (green) and O. tsutsugamushi (red) at 30 min (left panels), 1 h (middle panels), and 2 h (right panels). (B) Merged images of LAMP2 (green) and O. tsutsugamushi (red) at 30 min, 1 h, and 2 h. The ratios are the number of O. tsutsugamushi organisms that colocalized with EEA1 (A) or LAMP2 (B) to the total number of infecting O. tsutsugamushi organisms. The colocalization of O. tsutsugamushi with EEA1 or LAMP2 is indicated by arrows. Bars, 10 µm.
|
The results showed the effect that the treatment of cells with NH4Cl or bafilomycin A had on the colocalization of O. tsutsugamushi with EEA1 or LAMP2. There was colocalization of O. tsutsugamushi with EEA1 (Fig. 4A) when cells were treated with NH4Cl or bafilomycin A. In contrast, none of the O. tsutsugamushi organisms colocalized with LAMP2 at the times indicated in Fig. 4 in experiments with the same design (Fig. 4B). Furthermore, to clarify this result, O. tsutsugamushi infection was performed with or without these inhibitors for 6 h, 24 h, 48 h, and 72 h. It was interesting that there was replication of O. tsutsugamushi in the ECV304 cells without treatment with inhibitors (Fig. 5 bar C), whereas there was no replication in the cells treated with inhibitors (Fig. 5, bars B and N). In order to further analyze the status of O. tsutsugamushi 2 h postinfection in the cells treated with NH4Cl or bafilomycin A, we replaced inhibitor-supplemented medium with regular medium at 2 h postinfection. The results showed that the number of O. tsutsugamushi organisms increased in a time-dependent manner, as in the control (Fig. 5, bars BC and NC). In conclusion, we observed that growth and replication absolutely required the intracellular acidic compartments and vacuolar H+ ATPase, supporting our previous finding that intracellular O. tsutsugamushi moves toward the microtubule organizing center.
![]() View larger version (15K): [in a new window] |
FIG. 4. Colocalization of O. tsutsugamushi and early endosome antigen 1 or LAMP2 in the presence of NH4Cl (20 mM). Representative immunofluorescence as seen in confocal microscopic images of ECV304 cells infected with O. tsutsugamushi for the indicated time periods. Infected cells were washed, fixed, permeabilized, and double labeled with human serum against O. tsutsugamushi (goat anti-human rhodamine conjugate) together with anti-clathrin, anti-EEA1, or anti-LAMP2 (Alexa Fluor 488). (A) Colocalization of EEA1 (green) with O. tsutsugamushi (red) at 30 min, 1 h, and 2 h. (B) Colocalization of LAMP2 (green) with O. tsutsugamushi (red) at 30 min, 1 h, and 2 h. Ratios are the number of O. tsutsugamushi organisms that colocalized with EEA1 (A) or LAMP2 (B) to the total number of infecting O. tsutsugamushi organisms. The colocalization of O. tsutsugamushi with EEA1 or LAMP2 is indicated by arrows. Bars, 10 µm.
|
![]() View larger version (17K): [in a new window] |
FIG. 5. Effects of bafilomycin A and NH4Cl on O. tsutsugamushi infection. Cells were infected at 2 x 105 ICU for the indicated time periods in the presence or absence of bafilomycin A (20 nM) or NH4Cl (20 nM). ECV304 cells were fixed and labeled with KI-37 and goat anti-mouse IgG-FITC conjugate. Infective bacteria in every 100 cells were counted with a fluorescence microscope. Values represent the means from three independent experiments. C, control; BC, bafilomycin A-supplemented medium replaced with regular medium (without bafilomycin A); B, bafilomycin A-treated cells; NC, NH4Cl-supplemented medium replaced with regular medium (without NH4Cl); N, NH4Cl-treated cells.
|
|
|
|---|
Two major pathways, namely, the clathrin- and caveola-mediated pathways, are the most widely accepted mechanisms used by bacteria to become internalized by host cells (40). A number of studies have identified the invasive mechanism using a model system which introduces genes or proteins that are involved in a certain pathway or that uses biochemical inhibitors to block the expected steps. For instance, MDC, CPZ, and SUC are the biochemical inhibitors best known to interfere with the formation or recycling of the coated pit (9, 31, 45). In the clathrin-mediated endocytosis pathway, clathrin and
-adaptin serve as structural proteins to form the coated pit and are found during the early stage of bacterial invasion (50). Our result showed that O. tsutsugamushi was colocalized with clathrin or
-adaptin but not with caveolin 1 30 min postinfection and that MDC, CPZ, and SUC, but not filipin III, inhibited entry of the bacteria, indicating that the invasive mechanism of O. tsutsugamushi is the clathrin-dependent pathway. Furthermore, the colocalization of O. tsutsugamushi and transferrin was blocked by chlorpromazine HCl (data not shown), as expected. The bacterial invasive mechanism appeared to be largely dependent on the characteristics of the invasive microorganism and types of host cells. For instance, the exposure of primary human urethral epithelial cells to the transglutaminase inhibitor MDC resulted in an inhibition of Neisseria gonorrhoeae invasion of over 90% (15). In contrast, the pretreatment of Caco-2 cell monolayers with filipin III, which disrupts caveolae by chelating cholesterol, significantly reduced the ability of Campylobacter jejuni to enter these cells (30). Notably, it has been shown that Rickettsia, a very close family member of O. tsutsugamushi, uses a phagocytic pathway, not an endocytic pathway (48). In addition, when the chemicals that inhibit both endocytosis pathways (i.e., the clathrin- and caveola-dependent endocytosis pathways) were added to macrophages and infected with O. tsutsugamushi, no inhibition was found (data not shown), suggesting that the endocytic pathway is minimally involved in this experimental setting.
Once O. tsutsugamushi attaches to the receptor, it enters the endosomal compartments. Our data showed complete colocalization of O. tsutsugamushi with EEA1 between 10 and 30 min postinfection, indicating that the bacterial organisms target the early endosome at the beginning stage of invasion. Therefore, O. tsutsugamushi rapidly enters the host cell, and the majority of bacteria remain within the endosomal compartment for up to 1 h after invasion and are gradually trafficked to another compartment, such as the late endosome/lysosome. We then visualized the colocalization of O. tsutsugamushi with the lysosomal marker LAMP2 at 1 h postinfection. To our surprise, O. tsutsugamushi still remained in the late endosomes/lysosomes. Among intracellular bacteria, Listeria has been shown to escape the early endosome and multiply in the cytoplasm of infected cells (1). In most cases, specific mechanisms which lead to the disruption of the phagosomal membrane have been identified, thus allowing bacterial entry into the cytoplasm from the early endosome stage. In L. monocytogenes, the essential proteins that escape at the early endosome stage have been characterized, and they are the pore-forming lysteriolysin (LLO) and two phospholipase C proteins, PlcA and PlcB (46). Recently, it has been shown that Francisella tularensis utilizes mechanisms to escape from the late endosome/lysosome (14) which are distinct from those used by other intracellular bacterial pathogens, such as L. monocytogenes and Rickettsia conorii (48), to escape from the phagosome. The strategy of O. tsutsugamushi to escape from a compartment containing markers of a late endosome/lysosome is unusual for intracellular pathogens. A recent report has indicated that Bacillus anthracis, traditionally considered to have nonhemolytic genes, is capable, however, of expressing both hemolysins and phospholipases under anaerobic conditions (23). Gene sequencing of O. tsutsugamushi by our group has revealed the presence of hemolysin and hemolysin C genes (data not shown), and studies are under way to determine the functions and effects of these genes on the endosome lysis.
Exposure to the mildly acidic environment of endosomes causes conformational changes and triggers a fusion of bacterial membranes as well as endosomal membranes (7, 11, 41). Thus, we hypothesize that O. tsutsugamushi also undergoes the conformational changes associated with membrane fusion activity in the endosomes or lysosomes, which may be an essential process during the infectious life cycle of O. tsutsugamushi. In fact, we found that these acidic compartments are necessary for O. tsutsugamushi infection, since an inhibitor of vacuole-type ATPase, such as NH4Cl and bafilomycin A (BFLA1), completely blocks the bacterial protein synthesis. We have treated cells with NH4Cl or BFLA1 and observed the localization of O. tsutsugamushi in order to study when the escape occurs. There was no colocalization of LAMP2 with O. tsutsugamushi in the cells treated with NH4Cl or BFLA1. In addition, the replication rate of BFLA1- or NH4Cl-treated cells is very low compared to that of nontreated cells. This result suggests that the proton pump and low pH are essential requirements for O. tsutsugamushi to escape from the endosome to the cytosol.
In summary, the current study has demonstrated that O. tsutsugamushi enters endothelial cells and fibroblasts through the clathrin-mediated endocytic pathway and moves from the endosome to the cytosol at the phagosome/lysosome stage.
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»